A fresh $1.5M in Series A funding is heading to Xeris Pharmaceuticals, Inc., a biopharmaceutical company focused on improving patient lives. The growth-oriented firm develops and commercializes advanced products across a range of therapies.

Get the full Xeris Pharmaceuticals, Inc. company profile
Access contacts, investors, buying signals & more
A fresh $1.5M in Series A funding is heading to Xeris Pharmaceuticals, Inc., a biopharmaceutical company focused on improving patient lives. The growth-oriented firm develops and commercializes advanced products across a range of therapies.
Portfolio company of VentureWell

Double Blind Bio
Double Blind Bio builds AI agents that automate clinical trial workflows for sponsors and research sites, from site selection and feasibility through study startup and execution, so trials move faster and medicines reach patients sooner.
$7.0M Seed
today

Cityblock Health
Cityblock was founded in 2017 as the first tech-driven provider for communities with complex needs. We deliver better care to where it鈥檚 needed most, investing upstream in highly personalized, prevention-oriented health and social care to ultimately drive down costs and improve outcomes. Our tech enables scale by bringing together practical information, coordination, and communication for our members and our care teams. We are adamant about building a radically better member experience for people living in lower-income neighborhoods that have never been prioritized. And we won鈥檛 be satisfied with anything less than transforming the way that health services are delivered in previously underserved communities across the U.S. Join us! cityblock.com/careers
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 | ![]() NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Dolce Glow United States | Series a | $11.0M | 1d ago |
| 2 | ![]() FSH Technologies United States | Series a | $25.0M | 1d ago |
$116.0M Series e
1 day ago

FSH Technologies
FSH Technologies is the software platform for municipalities
$25.0M Series a
1 day ago
| $7.2B |
| 1y ago |
| 3 | ![]() Illumina United States | Unknown | $7.1B | 1y ago |
| 4 | ![]() GRAIL United States | Unknown | $7.1B | 1y ago |
| 5 | ![]() RemeGen Biosciences United States | Grant | $5.6B | 7mo ago |
| 3 |
![]() MaxQ Medical United States |
| Series a |
| $31.5M |
| 1d ago |
| 4 | ![]() Peeko | Series a | $7.0M | 2d ago |
| 5 | ![]() KaliVir Immunotherapeutics United States | Series a | $14.0M | 2d ago |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
See who invested in Xeris Pharmaceuticals, Inc. and reach their contacts directly.
Start free trialCarissa H.
Senior Director, Marketing Strategy
Mike M.
Regional Business Director, Rare Disease (Endocrinology)
Unlock 8 more key decision-makers at Xeris Pharmaceuticals, Inc. with verified emails and LinkedIn.
Start free trial
TuDOC
Recently received

Shyld AI
Recently received

Cardia, Inc.
Recently received